Preweaning Mn exposure leads to prolonged astrocyte activation and lasting effects on the dopaminergic system in adult male rats

Synapse

Volumn 65, Issue 6, 2011, Pages 532-544

  Kern, Cynthia H ^a   Smith, Donald R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrocyte; D1; D2; DA; DAT; GFAP; Lasting effects; Neonate exposure; Rat

Indexed keywords

DEXAMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; MANGANESE; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN REGION; CELL ACTIVATION; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BLOOD LEVEL; DOPAMINERGIC SYSTEM; EXPOSURE; FEMALE; LOCOMOTION; MALE; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; WEANING;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; DISEASE MODELS, ANIMAL; DOPAMINE; MALE; MANGANESE; MANGANESE POISONING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; UP-REGULATION; WEANING;

EID: 79953274203     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20873     Document Type: Article

References (112)

1. Aldskogius H, Kozlova EN. 1998. Central neuron-glial and glial-glial interactions following axon injury. Prog Neurobiol 55: 1-26.
2. Antonopoulos J, Dori I, Dinopoulos A, Chiotelli M, Parnavelas JG. 2002. Postnatal development of the dopaminergic system of the striatum in the rat. Neuroscience 110: 245-256.
3. Archer T, Fredriksson A. 1992. Functional changes implicating dopaminergic systems following perinatal treatments. Dev Pharmacol Ther 18(3-4): 201-222.
4. Arcus-Arth A, Krowech G, Zeise L. 2005. Breast milk and lipid intake distributions for assessing cumulative exposure and risk. J Expo Anal Environ Epidemiol 15: 357-365.
5. Arnsten AF. 2006. Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. J Clin Psychiatry 67 ( Suppl 8): 7-12.
6. Arnsten AF, Goldman-Rakic PS. 1998. Noise stress impairs prefrontal cortical cognitive function in monkeys: Evidence for a hyperdopaminergic mechanism. Arch Gen Psychiatry 55: 362-368.
7. Barhoumi R, Faske J, Liu X, Tjalkens RB. 2004. Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB. Brain Res Mol Brain Res 122: 167-179.
8. Barkley RA. 1997. Attention-deficit/hyperactivity disorder, self-regulation, and time: Toward a more comprehensive theory. J Dev Behav Pediatr 18: 271-279.
9. Barlow PJ. 1983. A pilot study on the metal levels in the hair of hyperactive children. Med Hypotheses 11: 309-318.
10. Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D. 2007a. Hair manganese and hyperactive behaviors: Pilot study of school-age children exposed through tap water. Environ Health Perspect 115: 122-127.
11. Bouchard M, Mergler D, Baldwin M, Panisset M, Bowler R, Roels HA. 2007b. Neurobehavioral functioning after cessation of manganese exposure: A follow-up after 14 years. Am J Ind Med 50: 831-840.
12. Brenneman KA, Cattley RC, Ali SF, Dorman DC. 1999. Manganese-induced developmental neurotoxicity in the CD rat: Is oxidative damage a mechanism of action? Neurotoxicology 20(2-3): 477-487.
13. Broaddus WC, Bennett JP, Jr. 1990a. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers. Brain Res Dev Brain Res 52(1-2): 265-271.
14. Broaddus WC, Bennett JP, Jr. 1990b. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function. Brain Res Dev Brain Res 52(1-2): 273-277.
15. Bronstein DM, Perez-Otano I, Sun V, Mullis Sawin SB, Chan J, Wu GC, Hudson PM, Kong LY, Hong JS, McMillian MK. 1995. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 704: 112-116.
16. Campbell A. 2004. Inflammation, neurodegenerative diseases, and environmental exposures. Ann NY Acad Sci 1035: 117-132.
17. Carr DB, O'Donnell P, Card JP, Sesack SR. 1999. Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens. J Neurosci 19: 11049-11060.
18. Carter SD, Hein JF, Rehnberg GL, Laskey JW. 1980. Chronic manganese oxide ingestion in rats: Hematological effects. J Toxicol Environ Health 6: 207-216.
19. Chandra SV, Shukla GS, Saxena DK. 1979. Manganese-induced behavioral dysfunction and its neurochemical mechanism in growing mice. J Neurochem 33: 1217-1221.
20. Chang JY, Liu LZ. 1999. Manganese potentiates nitric oxide production by microglia. Brain Res Mol Brain Res 68(1-2): 22-28.
21. Chen CJ, Liao SL, Huang YS, Chiang AN. 2005. RhoA inactivation is crucial to manganese-induced astrocyte stellation. Biochem Biophys Res Commun 326: 873-879.
22. Collipp PJ, Chen SY, Maitinsky S. 1983. Manganese in infant formulas and learning disability. Ann Nutr Metab 27: 488-494.
23. Cooper J, Bloom F, Roth R. The biochemical basis of neuropharmacology. 7th ed. New York:Oxford University Press, 1996.
24. Cory-Slechta DA, Pokora MJ, Widzowski DV. 1992. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist. Brain Res 598(1-2): 162-172.
25. Decker MJ, Jones KA, Solomon IG, Keating GL, Rye DB. 2005. Reduced extracellular dopamine and increased responsiveness to novelty: Neurochemical and behavioral sequelae of intermittent hypoxia. Sleep 28: 169-176.
26. DeLeo JA, Tanga FY, Tawfik VL. 2004. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10: 40-52.
27. Deskin R, Bursian SJ, Edens FW. 1981a. The effect of chronic manganese administration on some neurochemical and physiological variables in neonatal rats. Gen Pharmacol 12: 279-280.
28. Deskin R, Bursian SJ, Edens FW. 1981b. Neurochemical alterations induced by manganese chloride in neonatal rats. Neurotoxicology 2: 65-73.
29. Dewey KG, Heinig MJ, Nommsen LA, Lonnerdal B. 1991. Adequacy of energy intake among breast-fed infants in the DARLING study: Relationships to growth velocity, morbidity, and activity levels. Davis Area Research on Lactation, Infant Nutrition and Growth. J Pediatr 119: 538-547.
30. Dorman DC, McElveen AM, Marshall MW, Parkinson CU, James RA, Struve MF, Wong BA. 2005. Tissue manganese concentrations in lactating rats and their offspring following combined in utero and lactation exposure to inhaled manganese sulfate. Toxicol Sci 84: 12-21.
31. Dorman DC, Struve MF, Vitarella D, Byerly FL, Goetz J, Miller R. 2000. Neurotoxicity of manganese chloride in neonatal and adult CD rats following subchronic (21-day) high-dose oral exposure. JAppl Toxicol 20: 179-187.
32. Dorner K, Dziadzka S, Hohn A, Sievers E, Oldigs HD, Schulz-Lell G, Schaub J. 1989. Longitudinal manganese and copper balances in young infants and preterm infants fed on breast-milk and adapted cow's milk formulas. Br J Nutr 61: 559-572.
33. Ericson JE, Crinella FM, Clarke-Stewart KA, Allhusen VD, Chan T, Robertson RT. 2007. Prenatal manganese levels linked to childhood behavioral disinhibition. Neurotoxicol Teratol 29: 181-187.
34. Filipov NM, Seegal RF, Lawrence DA. 2005. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci 84: 139-148.
35. Girault JA, Greengard P. 2004. The neurobiology of dopamine signaling. Arch Neurol 61: 641-644.
36. Giulian D, Vaca K, Corpuz M. 1993. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13: 29-37.
37. Glaser PE, Thomas TC, Joyce BM, Castellanos FX, Gerhardt GA. 2005. Differential effects of amphetamine isomers on dopamine in the rat striatum and nucleus accumbens core. Psychopharmacology 178: 250-258.
38. Godbole VY, Grundleger ML, Pasquine TA, Thenen SW. 1981. Composition of rat milk from day 5 to 20 of lactation and milk intake of lean and preobese Zucker pups. J Nutr 111: 480-487.
39. Golub MS, Hogrefe CE, Germann SL, Tran TT, Beard JL, Crinella FM, Lonnerdal B. 2005. Neurobehavioral evaluation of rhesus monkey infants fed cow's milk formula, soy formula, or soy formula with added manganese. Neurotoxicol Teratol 27: 615-627.
40. Hallett PJ, Spoelgen R, Hyman BT, Standaert DG, Dunah AW. 2006. Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. J Neurosci 26: 4690-4700.
41. Hazell AS. 2002. Astrocytes and manganese neurotoxicity. Neurochem Int 41: 271-277.
42. Hazell AS, Normandin L, Norenberg MD, Kennedy G, Yi JH. 2006. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci Lett 396: 167-171.
43. He P, Liu DH, Zhang GQ. 1994. Effects of high-level-manganese sewage irrigation on children's neurobehavior. Zhonghua Yu Fang Yi Xue Za Zhi 28: 216-218.
44. Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB. 1999. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410: 215-228.
45. Heales SJR. 2004. Neurodegeneration or neuroprotection: The pivotal role of astrocytes. Neurochemical Res 29: 513-519.
46. Hernandez-Lopez S, Tkatch T, Perez-Garci E, Galarraga E, Bargas J, Hamm H, Surmeier DJ. 2000. D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLCβ1-IP3-calcineurin-signaling cascade. J Neurosci 20: 8987-8995.
47. Huang CC, Chu NS, Lu CS, Chen RS, Calne DB. 1998. Long-term progression in chronic manganism: ten years of follow-up. Neurology 50: 698-700.
48. Huang CC, Lu CS, Chu NS, Hochberg F, Lilienfeld D, Olanow W, Calne DB. 1993. Progression after chronic manganese exposure. Neurology 43: 1479-1483.
49. Hunot S, Hirsch EC. 2003. Neuroinflammatory processes in Parkinson's disease. Ann Neurol 53 ( Suppl 3): S49-S58; discussion S58-S60.
50. Hurley MJ, Jenner P. 2006. What has been learnt from study of dopamine receptors in Parkinson's disease? Pharmacol Ther 111: 715-728.
51. Jayakumar AR, Rama Rao KV, Kalaiselvi P, Norenberg MD. 2004. Combined effects of ammonia and manganese on astrocytes in culture. Neurochem Res 29: 2051-2056.
52. Keen CL, Lonnerdal B, Clegg M, Hurley LS. 1981. Developmental changes in composition of rat milk: Trace elements, minerals, protein, carbohydrate and fat. J Nutr 111: 226-236.
53. Kern C, Stanwood G, Smith D. 2010. Pre-weaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse 64: 363-378.
54. Kessler KR, Wunderlich G, Hefter H, Seitz RJ. 2003. Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density. Mov Disord 18: 217-218.
55. Kontur PJ, Fechter LD. 1985. Brain manganese, catecholamine turnover, and the development of startle in rats prenatally exposed to manganese. Teratology 32: 1-11.
56. Kostial K, Kello D, Jugo S, Rabar I, Maljkovic T. 1978. Influence of age on metal metabolism and toxicity. Environ Health Perspect 25: 81-86.
57. Lai JC, Leung TK, Lim L. 1984. Differences in the neurotoxic effects of manganese during development and aging: Some observations on brain regional neurotransmitter and non-neurotransmitter metabolism in a developmental rat model of chronic manganese encephalopathy. Neurotoxicology 5: 37-47.
58. Liu X, Buffington JA, Tjalkens RB. 2005. NF-kappaB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines. Brain Res Mol Brain Res 141: 39-47.
59. Liu X, Sullivan KA, Madl JE, Legare M, Tjalkens RB. 2006. Manganese-induced neurotoxicity: The role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol Sci 91: 521-531.
60. Ljung K, Vahter M. 2007. Time to re-evaluate the guideline value for manganese in drinking water? Environ Health Perspect 115: 1533-1538.
61. Lonnerdal B. 1997. Effects of milk and milk components on calcium, magnesium, and trace element absorption during infancy. Physiol Rev 77: 643-669.
62. Lucchini R, Apostoli P, Perrone C, Placidi D, Albini E, Migliorati P, Mergler D, Sassine MP, Palmi S, Alessio L. 1999. Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 20(2-3): 287-297.
63. Marlowe M. 1993. Hair element concentrations and young children's behavior at school and home. Orthomol Med 27: 488-494.
64. McDougall SA, Reichel CM, Farley CM, Flesher MM, Der-Ghazarian T, Cortez AM, Wacan JJ, Martinez CE, Varela FA, Butt AE, Crawford CA. 2008. Postnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processes. Neuroscience 154: 848-860.
65. McGeer PL, McGeer EG. 2002. Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol 8: 529-538.
66. McMahon SB, Cafferty WB, Marchand F. 2005. Immune and glial cell factors as pain mediators and modulators. Exp Neurol 192: 444-462.
67. McMillan DE. 1999. A brief history of the neurobehavioral toxicity of manganese: Some unanswered questions. Neurotoxicology 20(2-3): 499-507.
68. Mena I. 1974. The role of manganese in human disease. Ann Clin Lab Sci 4: 487-491.
69. Mergler D, Huel G, Bowler R, Iregren A, Belanger S, Baldwin M, Tardif R, Smargiassi A, Martin L. 1994. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res 64: 151-180.
70. Minghetti L. 2005. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 18: 315-321.
71. Minghetti L, Ajmone-Cat MA, De Berardinis MA, De Simone R. 2005. Microglial activation in chronic neurodegenerative diseases: Roles of apoptotic neurons and chronic stimulation. Brain Res Brain Res Rev 48: 251-256.
72. Moreno JA, Sullivan KA, Carbone DL, Hanneman WH, Tjalkens RB. 2008. Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways. J Neurosci Res 86: 2028-2038.
73. Normandin L, Hazell AS. 2002. Manganese neurotoxicity: An update of pathophysiologic mechanisms. Metab Brain Dis 17: 375-387.
74. Nowak P, Brus R, Kostrzewa RM. 2001. Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol J Pharmacol 53: 319-329.
75. NRC. 1996. National Research Council. Guide for the care and use of laboratory animals. Washington D.C.: National Academy Press.
76. Oades RD, Sadile AG, Sagvolden T, Viggiano D, Zuddas A, Devoto P, Aase H, Johansen EB, Ruocco LA, Russell VA. 2005. The control of responsiveness in ADHD by catecholamines: Evidence for dopaminergic, noradrenergic and interactive roles. Dev Sci 8: 122-131.
77. Pappas BA, Zhang D, Davidson CM, Crowder T, Park GA, Fortin T. 1997. Perinatal manganese exposure: Behavioral, neurochemical, and histopathological effects in the rat. Neurotoxicol Teratol 19: 17-25.
78. Parish CL, Finkelstein DI, Drago J, Borrelli E, Horne MK. 2001. The role of dopamine receptors in regulating the size of axonal arbors. J Neurosci 21: 5147-5157.
79. Pattij T, Janssen MC, Vanderschuren LJ, Schoffelmeer AN, van Gaalen MM. 2007. Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl) 191: 587-598.
80. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 4th ed. Academic Press, San Diego, USA 1998.
81. Perry VH. 2004. The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease. Brain Behav Immun 18: 407-413.
82. Pihl RO, Parkes M. 1977. Hair element content in learning disabled children. Science 198: 204-206.
83. Prut L, Belzung C. 2003. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1-3): 3-33.
84. Ramesh GT, Ghosh D, Gunasekar PG. 2002. Activation of early signaling transcription factor. NF-kappaB following low-level manganese exposure. Toxicol Lett 136: 151-158.
85. Reichel CM, Wacan JJ, Farley CM, Stanley BJ, Crawford CA, McDougall SA. 2006. Postnatal manganese exposure attenuates cocaine-induced locomotor activity and reduces dopamine transporters in adult male rats. Neurotoxicol Teratol 28: 323-332.
86. Roels H, Lauwerys R, Buchet JP, Genet P, Sarhan MJ, Hanotiau I, de Fays M, Bernard A, Stanescu D. 1987. Epidemiological survey among workers exposed to manganese: Effects on lung, central nervous system, and some biological indices. Am J Ind Med 11: 307-327.
87. Roels HA, Ortega Eslava MI, Ceulemans E, Robert A, Lison D. 1999. Prospective study on the reversibility of neurobehavioral effects in workers exposed to manganese dioxide. Neurotoxicology 20(2-3): 255-271.
88. Russell VA. 2003. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder-The spontaneously hypertensive rat. Neurosci Biobehav Rev 27: 671-682.
89. Seth PK, Husain R, Mushtaq M, Chandra SV. 1977. Effect of manganese on neonatal rat: Manganese concentration and enzymatic alterations in brain. Acta Pharmacol Toxicol (Copenh) 40: 553-560.
90. Smith DR, Osterloh JD, Niemeyer S, Flegal AR. 1992. Stable isotope labeling of lead compartments in rats with ultralow lead concentrations. Environ Res 57: 190-207.
91. Snyder GL, Allen PB, Fienberg AA, Valle CG, Huganir RL, Nairn AC, Greengard P. 2000. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neurosci 20: 4480-4488.
92. Spranger M, Schwab S, Desiderato S, Bonmann E, Krieger D, Fandrey J. 1998. Manganese augments nitric oxide synthesis in murine astrocytes: A new pathogenetic mechanism in manganism? Exp Neurol 149: 277-283.
93. Stastny D, Vogel RS, Picciano MF. 1984. Manganese intake and serum manganese concentration of human milk-fed and formula-fed infants. Am J Clin Nutr 39: 872-878.
94. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. 2007. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30: 228-235.
95. Takser L, Mergler D, Hellier G, Sahuquillo J, Huel G. 2003. Manganese, monoamine metabolite levels at birth, and child psychomotor development. Neurotoxicology 24(4-5): 667-674.
96. Tanga FY, Raghavendra V, DeLeo JA. 2004. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45(2-3): 397-407.
97. Tepper JM, Sharpe NA, Koos TZ, Trent F. 1998. Postnatal development of the rat neostriatum: Electrophysiological, light- and electron-microscopic studies. Dev Neurosci 20(2-3): 125-145.
98. Thomas WS, Neal-Beliveau BS, Joyce JN. 1998. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum. Brain Res Dev Brain Res 111: 99-106.
99. Tran TT, Chowanadisai W, Crinella FM, Chicz-DeMet A, Lonnerdal B. 2002a. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 23(4-5): 635-643.
100. Tran TT, Chowanadisai W, Lonnerdal B, Le L, Parker M, Chicz-Demet A, Crinella FM. 2002b. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 23(4-5): 645-651.
101. Verity MA. 1999. Manganese neurotoxicity: A mechanistic hypothesis. Neurotoxicology 20(2-3): 489-497.
102. Wasserman GA, Liu X, Parvez F, Ahsan H, Levy D, Factor-Litvak P, Kline J, van Geen A, Slavkovich V, LoIacono NJ, Cheng Z, Zheng Y, Graziano JH. 2006. Water manganese exposure and children's intellectual function in Araihazar. Bangladesh. Environ Health Perspect 114: 124-129.
103. Widzowski DV, Finkelstein JN, Pokora MJ, Cory-Slechta DA. 1994. Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity. Neurotoxicology 15: 853-865.
104. Winstanley CA, Eagle DM, Robbins TW. 2006. Behavioral models of impulsivity in relation to ADHD: Translation between clinical and preclinical studies. Clin Psychol Rev 26: 379-395.
105. Woolf A, Wright R, Amarasiriwardena C, Bellinger D. 2002. A child with chronic manganese exposure from drinking water. Environ Health Perspect 110: 613-616.
106. Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC. 2006. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 27: 210-216.
107. Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H. 1986. Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 70(3-4): 273-278.
108. Yin Z, Aschner JL, dos Santos AP, Aschner M. 2008. Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res 1203: 1-11.
109. Yoon M, Barton HA. 2008. Predicting maternal rat and pup exposures: how different are they? Toxicol Sci 102: 15-32.
110. Zhang G, Liu D, He P. 1995. Effects of manganese on learning abilities in school children. Zhonghua Yu Fang Yi Xue Za Zhi 29: 156-158.
111. Zhao F, Cai T, Liu M, Zheng G, Luo W, Chen J. 2009. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol Sci 107: 156-164.
112. Zwingmann C, Leibfritz D, Hazell AS. 2003. Energy metabolism in astrocytes and neurons treated with manganese: Relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. JCereb Blood Flow Metab 23: 756-771.